Literature DB >> 17113749

Host susceptibility to tuberculosis: CARD15 polymorphisms in a South African population.

Marlo Möller1, Almut Nebel, Ruta Kwiatkowski, Paul D van Helden, Eileen G Hoal, Stefan Schreiber.   

Abstract

Tuberculosis (TB) is one of the leading causes of death worldwide. The nucleotide-binding oligomerisation domain 2 protein (NOD2) has recently been recognised as a non-redundant recognition mechanism of Mycobacterium tuberculosis. The caspase recruitment domain-containing protein 15 gene (CARD15), which encodes the NOD2 protein, is a susceptibility gene for Crohn's disease (CD), a granulomatous, chronic inflammatory disorder. CARD15 was therefore investigated as a candidate gene in TB. We genotyped the R702W, G908R and 1007fs variants, previously associated with CD, in TB cases and controls from the admixed South African Coloured population. No statistically significant differences between cases and controls were observed for these variants. We determined that the CD-associated mutations occur at very low frequencies in this population. Our results indicate that CARD15 is not a major susceptibility gene for TB in the South African Coloureds.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17113749     DOI: 10.1016/j.mcp.2006.10.001

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  15 in total

Review 1.  Unleashing the therapeutic potential of NOD-like receptors.

Authors:  Kaoru Geddes; João G Magalhães; Stephen E Girardin
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

2.  Common polymorphisms in the NOD2 gene region are associated with leprosy and its reactive states.

Authors:  William Richard Berrington; Murdo Macdonald; Saraswoti Khadge; Bishwa Raj Sapkota; Marta Janer; Deanna Alisa Hagge; Gilla Kaplan; Thomas Richard Hawn
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

Review 3.  Early clearance of Mycobacterium tuberculosis: a new frontier in prevention.

Authors:  Ayesha J Verrall; Mihai G Netea; Bachti Alisjahbana; Philip C Hill; Reimout van Crevel
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

Review 4.  Immune-related gene polymorphisms in pulmonary diseases.

Authors:  Dhirendra P Singh; Prathyusha Bagam; Malaya K Sahoo; Sanjay Batra
Journal:  Toxicology       Date:  2017-03-30       Impact factor: 4.221

Review 5.  Innate immune gene polymorphisms in tuberculosis.

Authors:  Abul K Azad; Wolfgang Sadee; Larry S Schlesinger
Journal:  Infect Immun       Date:  2012-07-23       Impact factor: 3.441

6.  Host genome polymorphisms and tuberculosis infection: What we have to say?

Authors:  Said Alfin Khalilullah; Harapan Harapan; Nabeeh A Hasan; Wira Winardi; Ichsan Ichsan; Mulyadi Mulyadi
Journal:  Egypt J Chest Dis Tuberc       Date:  2013-12-17

7.  Heparin-binding hemagglutinin induces IFN-γ(+) IL-2(+) IL-17(+) multifunctional CD4(+) T cells during latent but not active tuberculosis disease.

Authors:  André G Loxton; Gillian F Black; Kim Stanley; Gerhard Walzl
Journal:  Clin Vaccine Immunol       Date:  2012-03-29

Review 8.  Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?

Authors:  William R Berrington; Thomas R Hawn
Journal:  Immunol Rev       Date:  2007-10       Impact factor: 12.988

9.  Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis.

Authors:  Sheetal Gandotra; Sihyug Jang; Peter J Murray; Padmini Salgame; Sabine Ehrt
Journal:  Infect Immun       Date:  2007-08-20       Impact factor: 3.441

Review 10.  Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics.

Authors:  Giorgio Sirugo; Branwen J Hennig; Adebowale A Adeyemo; Alice Matimba; Melanie J Newport; Muntaser E Ibrahim; Kelli K Ryckman; Alessandra Tacconelli; Renato Mariani-Costantini; Giuseppe Novelli; Himla Soodyall; Charles N Rotimi; Raj S Ramesar; Sarah A Tishkoff; Scott M Williams
Journal:  Hum Genet       Date:  2008-05-30       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.